Evidence map›Paper›PMID 40603572›Full record

ArticleScientific reports2025

Enhancing breast cancer diagnosis through machine learning algorithms.

Javad Amraei, Aboulfazl Mirzapoor, Kiomars Motarjem, Mohammad Abdolahad

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Javad AmraeiDepartment of Nanobiotechnology, Faculty of Biological Sciences, Tarbiat Modares University, P.O. Box 14115-175, Tehran, Iran.
Aboulfazl MirzapoorDepartment of Nanobiotechnology, Faculty of Biological Sciences, Tarbiat Modares University, P.O. Box 14115-175, Tehran, Iran. a.mirzapour@modares.ac.ir.
Kiomars MotarjemDepartment of Statistics, Faculty of Mathematical Sciences, Tarbiat Modares University, P.O. Box 14117-13116, Tehran, Iran.
Mohammad AbdolahadNano Bio Electronic Devices Lab, School of Electrical and Computer Engineering, College of Engineering, University of Tehran, Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Among the most important health concerns in the world, and the number one cause of death in women, is breast cancer. Bearing in mind that there are more than 100 types of cancer, each presenting different symptoms, its early detection is indeed a big challenge. The prevalence of breast cancer indicates the prudent need for effective diagnostic and prognostic approaches. From 2016 to 2020, 19.6 deaths per 100, 000 women occurred annually due to breast cancer-a factor indicating the importance of early treatments. Machine Learning has become important for the improvement of early diagnosis and prognosis that may have the potential to reduce mortality rates. Some considerable volume of research work has been carried out on the use of Machine Learning algorithms for accurate diagnosis of breast cancer. In this research has done extensive algorithm evaluation like SVM, DT, RF, Logistic regression, KNN and ANN using datasets CDP Breast Cancer. The important performance indicators observed for each of these algorithms included accuracy, precision, recall, sensitivity, and specificity. These findings are an important step forward in the application of Machine Learning to improve diagnostic accuracy, thus enabling early detection and mitigating the major consequences of breast cancer on global health.

Indexed as

Breast NeoplasmsEarly Detection of CancerMachine LearningAlgorithmsFemaleHumansPrognosisBreast cancerCDP Nano BiosensorEarly detectionMachine learning

Identifiers

PMID40603572
PMCPMC12222905

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.